Screener
Vaxcyte, Inc. PCVX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss from operations | (345,850) | (180,793) |
| Other income, net: | ||
| Interest income | 26,610 | 32,935 |
| Other income (expense) | (1,382) | 7,140 |
| Total other income, net | 25,228 | 40,075 |
| Net loss | $(320,622) | $(140,718) |
| Net loss per share, basic and diluted | $(2.30) | $(1.04) |
| Weighted-average shares outstanding, basic and diluted | 139,506,680 | 135,690,949 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s shares (diluted)?
- Vaxcyte, Inc. (PCVX) reported shares (diluted) of 139.5M in Q1 2026.
- How has Vaxcyte, Inc.'s shares (diluted) changed year-over-year?
- Vaxcyte, Inc.'s shares (diluted) increased by 2.8% year-over-year, from 135.7M to 139.5M.
- What is the long-term trend for Vaxcyte, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s shares (diluted) has grown at a 27.4% compound annual growth rate (CAGR), from 206.8M to 544M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Vaxcyte, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude